| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $323K | -81.6% | -83.4% |
| R&D Expense | $6.0M | +18.2% | +17.9% |
| SG&A Expense | $2.3M | -28.8% | +5.2% |
| Operating Income | -$8.0M | -21.6% | -49.1% |
| Net Income | -$7.7M | -23.5% | -62.5% |
| EPS (Basic) | -$0.84 | -20.0% | -52.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.4M | +13.4% | +21.9% |
| Short-term Investments | $17.9M | -29.2% | -54.1% |
| Current Assets | $30.6M | -19.6% | -37.3% |
| Total Assets | $30.6M | -19.6% | -37.4% |
| Total Liabilities | $4.6M | -0.9% | +41.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.9M | — | — |
| Investing Cash Flow | $12.7M | — | — |
| Financing Cash Flow | $4.6M | — | — |
| $26.0M |
| -22.2% |
| -43.0% |